ATOMOXETINE HYDROCHLORIDE | A202682 | HETERO LABS LTD UNIT V
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Rosemont Pharmaceuticals Holdings, Inc. FDA-2025-P-6868 · 7 docket documents Rosemont Pharmaceuticals Holdings, Inc. filed this citizen petition requesting that the FDA determine the discontinued Strattera (atomoxetine hydrochloride) 10, 18, 25, 40, 60, 80, and 100 mg capsules (NDA 021411) from Eli Lilly and Company were not discontinued due to safety or efficacy reasons, as | 505(q) | 2025-12-09 | Granted | Rosemont Pharmaceuticals Holdings, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.5489
per ea
Lowest NADAC/Unit
$0.3514
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722071930ATOMOXETINE HCL 80 MG CAPSULE | $0.5489 | EA | Generic | — | 2026-06-17 |
| 31722072030ATOMOXETINE HCL 100 MG CAPSULE | $0.5341 | EA | Generic | — | 2026-06-17 |
| 31722071830ATOMOXETINE HCL 60 MG CAPSULE | $0.4969 | EA | Generic | — | 2026-06-17 |
| 31722071730ATOMOXETINE HCL 40 MG CAPSULE | $0.4769 | EA | Generic | — | 2026-06-17 |
| 31722071530ATOMOXETINE HCL 18 MG CAPSULE | $0.4670 | EA | Generic | — | 2026-06-17 |
| 31722071630ATOMOXETINE HCL 25 MG CAPSULE | $0.4050 | EA | Generic | — | 2026-06-17 |
| 31722071430ATOMOXETINE HCL 10 MG CAPSULE | $0.3514 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.